Phase 2 Acute Monocytic Leukemia Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Acute Myeloid LeukemiaAcute Monocytic Leukemia

OHSU Knight Cancer Institute40 enrolled2 locationsNCT06504459

Recruiting

Phase 2

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Acute Monocytic Leukemia

Chinese PLA General Hospital204 enrolled3 locationsNCT07512700

Recruiting

Phase 2

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Newly DiagnosedAcute Monocytic Leukemia

The First Affiliated Hospital of Soochow University92 enrolled1 locationNCT05566054